• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

About FDA

  • Print
  • Share
  • E-mail

Office of Policy and Planning

Peter G. Lurie, M.D., M.P.H., Acting Associate Commissioner

Mission

The Office of Policy and Planning (OPP) provides strategic policy direction, planning, and data-driven analysis for the Food and Drug Administration (FDA) to more effectively and efficiently protect and promote the public health. 

OPP does this by:

  • developing significant and cross-cutting policy and engaging in strategic problem solving;
  • serving as FDA’s focal point for the development, coordination, oversight, and processing of regulations, guidances and other policy documents;
  • conducting economic analyses, program evaluations, and special studies;  
  • leading overall FDA strategic, performance, and business process planning, including the development of outcome measures; and

Major Functions

  • Advises the Commissioner and other key agency officials on matters relating to agency policy, regulations development, legislative issues, risk communication, and planning and evaluation activities.
  • Provides strategic policy direction, planning, and data-driven analysis for FDA to more effectively and efficiently protect and promote public health.
  • Develops significant and cross-cutting policy and engages in strategic problem solving.
  • Serves as FDA’s focal point for the development, coordination, oversight, and processing of regulations, guidance and other policy documents.
  • Conducts economic analyses, program evaluations, and special studies.
  • Leads overall FDA strategic, performance and business process planning, including the development of performance measures
  • Leads and coordinates agency-wide efforts to plan, evaluate and improve FDA risk communication.

Contact the Office of Policy and Planning

Acting Associate Commissioner: Peter G. Lurie, M.D., M.P.H.
Phone: 301-796-4800 | Fax: 301-847-8616 | Email: peter.lurie@fda.hhs.gov

White Oak Office:
Food and Drug Administration
Office of Policy and Planning
Building 32, 10903 New Hampshire Avenue, Silver Spring, MD 20993

 

-